Highly Dilutive Offering: EXOZYMES Raises $5.3M with Warrants Priced Below Market
EXOZ sits 32% above its 52-week low of $7.08.
Summary
EXOZYMES Inc. priced a public offering of common stock and warrants, raising approximately $5.33 million in gross proceeds. This financing is critical for the company, which previously disclosed substantial doubt about its ability to continue as a going concern and reported declining cash. However, the offering amount is significantly less than the $10M-$15M previously targeted in earlier filings. The terms are highly dilutive, with units effectively pricing shares at $9.00, below the current market price of $9.34, and warrants including a reset clause to $0.001 if future offerings are below $8.99. The offering is expected to close on June 9, 2026.
At the time of this announcement, EXOZ was trading at $9.34 on NASDAQ in the Life Sciences sector. The 52-week trading range was $7.08 to $18.40. This news item was assessed with negative market sentiment and an importance score of 9 out of 10. Source: ACCESS Newswire.